Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms. | Int J Mol Sci | 2023 | 36769214 | PubTator, text mining | PubMed |
| DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival. | Int J Mol Sci | 2023 | 36769087 | PubTator, text mining | PubMed |
| The ATR Inhibitor VE-821 Enhances the Radiosensitivity and Suppresses DNA Repair Mechanisms of Human Chondrosarcoma Cells. | Int J Mol Sci | 2023 | 36768638 | PubTator, text mining | PubMed |
| Neural Tube Defects and Folate Deficiency: Is DNA Repair Defective? | Int J Mol Sci | 2023 | 36768542 | PubTator, text mining | PubMed |
| Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? | Int J Mol Sci | 2023 | 36768460 | PubTator, text mining | PubMed |
| PARP Inhibitors and Proteins Interacting with SLX4. | Cancers (Basel) | 2023 | 36765954 | PubTator, text mining | PubMed |
| Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies. | Cancers (Basel) | 2023 | 36765950 | PubTator, text mining | PubMed |
| Hereditary polyposis syndromes remain a challenging disease entity: Old dilemmas and new insights. | World J Gastrointest Surg | 2023 | 36741069 | PubTator, text mining | PubMed |
| FXR1 facilitates axitinib resistance in clear cell renal cell carcinoma via regulating KEAP1/Nrf2 signaling pathway. | Anticancer Drugs | 2023 | 36730618 | PubTator, text mining | PubMed |
| Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms. | Nat Commun | 2023 | 36720864 | PubTator, text mining | PubMed |
| Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. | Mol Med | 2023 | 36717774 | PubTator, text mining | PubMed |
| Intratumoral Heterogeneity and Clonal Evolution Induced by HPV Integration. | Cancer Discov | 2023 | 36715691 | PubTator, text mining | PubMed |
| Genetically engineered mouse models for hereditary cancer syndromes. | Cancer Sci | 2023 | 36715493 | PubTator, text mining | PubMed |
| Germline heterozygous exons 8-11 pathogenic BARD1 gene deletion reported for the first time in a family with suspicion of a hereditary colorectal cancer syndrome: more than an incidental finding? | Hered Cancer Clin Pract | 2023 | 36709314 | PubTator, text mining | PubMed |
| The complementary roles of genome-wide approaches in identifying genes linked to an inherited risk of colorectal cancer. | Hered Cancer Clin Pract | 2023 | 36707860 | PubTator, text mining | PubMed |
| Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. | Cancer Discov | 2023 | 36700848 | PubTator, text mining | PubMed |
| Exosomal circ-PTPN22 and circ-ADAMTS6 mark T cell exhaustion and neutrophil extracellular traps in Asian intrahepatic cholangiocarcinoma. | Mol Ther Nucleic Acids | 2023 | 36700045 | PubTator, text mining | PubMed |
| T-2 toxin-induced intestinal damage with dysregulation of metabolism, redox homeostasis, inflammation, and apoptosis in chicks. | Arch Toxicol | 2023 | 36695871 | PubTator, text mining | PubMed |
| Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management. | Clin Cancer Res | 2023 | 36693186 | PubTator, text mining | PubMed |
| Characterization of a germline variant MSH6 c.4001G > C in a Lynch syndrome family. | Mol Genet Genomic Med | 2023 | 36691871 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=20